University of Michigan Med. Ctr Htc — Ann Arbor, Michigan

University of Michigan Med. Ctr Htc is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Michigan Med. Ctr Htc has participated in 1 clinical trials.

Therapeutic areas: Hemophilia A.

Sponsors: Baxalta now part of Shire.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Med. Ctr Htc?

University of Michigan Med. Ctr Htc has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Med. Ctr Htc conducted?

University of Michigan Med. Ctr Htc has 1 clinical trials on record. Their work covers Hemophilia A.

Is University of Michigan Med. Ctr Htc accredited by Crixeo Health?

University of Michigan Med. Ctr Htc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Med. Ctr Htc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.